Penumbra, Inc Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments
Penumbra, Inc (PEN) reported Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments of $37.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-27.
Discontinued › Income Statement › Other Income
us-gaap:AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments · last filed 2018-02-27
- Penumbra, Inc available-for-sale securities, gross realized gain (loss), excluding other than temporary impairments for the quarter ending 2017-03-31 was $31.00K.
- Penumbra, Inc available-for-sale securities, gross realized gain (loss), excluding other than temporary impairments for the quarter ending 2016-12-31 was $5.00K.
- Penumbra, Inc available-for-sale securities, gross realized gain (loss), excluding other than temporary impairments for the quarter ending 2016-09-30 was $1.00K.
- Penumbra, Inc available-for-sale securities, gross realized gain (loss), excluding other than temporary impairments for the quarter ending 2016-06-30 was $2.00K.
- Penumbra, Inc available-for-sale securities, gross realized gain (loss), excluding other than temporary impairments for fiscal 2017 was $37.00K, a 362.50% increase from fiscal 2016.
- Penumbra, Inc available-for-sale securities, gross realized gain (loss), excluding other than temporary impairments for fiscal 2016 was $8.00K.
- Penumbra, Inc available-for-sale securities, gross realized gain (loss), excluding other than temporary impairments for fiscal 2015 was -$541.00K.
- Penumbra, Inc available-for-sale securities, gross realized gain (loss), excluding other than temporary impairments for fiscal 2014 was $0.00.
| Period end | Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments 3 month | Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments 6 month | Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments 9 month | Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments 12 month |
|---|---|---|---|---|
| 2017-12-31 | $37.00K 10-K · filed 2018-02-27 | |||
| 2017-03-31 | $31.00K 10-Q · filed 2017-05-09 | $36.00K derived: sum of 2 quarters · filed 2018-02-27 | $37.00K derived: sum of 3 quarters · filed 2018-02-27 | $39.00K derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $6.00K derived: sum of 2 quarters · filed 2018-02-27 | $8.00K derived: sum of 3 quarters · filed 2018-02-27 | $8.00K 10-K · filed 2018-02-27 |
| 2016-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $3.00K derived: sum of 2 quarters · filed 2016-11-03 | $3.00K 10-Q · filed 2016-11-03 | $3.00K derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $2.00K 10-Q · filed 2016-08-09 | $2.00K derived: sum of 3 quarters · filed 2018-02-27 | $2.00K derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $0.00 10-Q · filed 2017-05-09 | $0.00 derived: sum of 2 quarters · filed 2018-02-27 | $0.00 derived: sum of 3 quarters · filed 2018-02-27 | |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $0.00 derived: sum of 2 quarters · filed 2018-02-27 | -$541.00K 10-K · filed 2018-02-27 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$541.00K 10-Q · filed 2016-11-03 | ||
| 2015-06-30 | -$541.00K 10-Q · filed 2016-08-09 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $0.00 10-K · filed 2017-02-28 | ||
| 2014-09-30 | $0.00 10-Q · filed 2015-11-12 | |||
| 2013-12-31 | -$160.00K 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |